These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 33329554

  • 1. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E, Carrillo J, Urrea V, Rigau J, Alegre J, Cabrera C, Oltra E, Castro-Marrero J, Blanco J.
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.
    J Transl Med; 2011 May 28; 9():81. PubMed ID: 21619669
    [Abstract] [Full Text] [Related]

  • 5. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM, King EC, Lee JS, Sepúlveda N, Wolf AS, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM.
    Front Immunol; 2019 May 28; 10():796. PubMed ID: 31057538
    [Abstract] [Full Text] [Related]

  • 6. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.
    BMC Immunol; 2015 Jun 02; 16():35. PubMed ID: 26032326
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.
    J Transl Med; 2012 May 09; 10():88. PubMed ID: 22571715
    [Abstract] [Full Text] [Related]

  • 8. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Balinas C, Eaton-Fitch N, Staines D, Marshall-Gradisnik S.
    Mol Med; 2019 Apr 23; 25(1):14. PubMed ID: 31014226
    [Abstract] [Full Text] [Related]

  • 9. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, Marshall-Gradisnik S.
    Scand J Immunol; 2016 Jan 23; 83(1):44-51. PubMed ID: 26381393
    [Abstract] [Full Text] [Related]

  • 10. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
    Petty RD, McCarthy NE, Le Dieu R, Kerr JR.
    PLoS One; 2016 Jan 23; 11(3):e0150904. PubMed ID: 26967895
    [Abstract] [Full Text] [Related]

  • 11. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik S.
    BMC Pharmacol Toxicol; 2018 Mar 27; 19(1):12. PubMed ID: 29587879
    [Abstract] [Full Text] [Related]

  • 12. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
    Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.
    J Transl Med; 2013 Mar 20; 11():68. PubMed ID: 23514202
    [Abstract] [Full Text] [Related]

  • 13. Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing.
    Sun Y, Zhang Z, Qiao Q, Zou Y, Wang L, Wang T, Lou B, Li G, Xu M, Wang Y, Zhang Z, Hou X, Chen L, Zhao R.
    J Transl Med; 2024 Oct 11; 22(1):925. PubMed ID: 39394558
    [Abstract] [Full Text] [Related]

  • 14. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T, Johnston S, Chacko A, Gibson D, Cepon J, Smith P, Staines D, Marshall-Gradisnik S.
    Asian Pac J Allergy Immunol; 2017 Jun 11; 35(2):75-81. PubMed ID: 27362406
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2015 Sep 14; 13():299. PubMed ID: 26370228
    [Abstract] [Full Text] [Related]

  • 16. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Balinas C, Cabanas H, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2019 Dec 03; 17(1):401. PubMed ID: 31796045
    [Abstract] [Full Text] [Related]

  • 17. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H, Muraki K, Eaton-Fitch N, Staines DR, Marshall-Gradisnik S.
    Front Immunol; 2021 Dec 03; 12():687806. PubMed ID: 34326841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S.
    Mol Med; 2018 Aug 14; 24(1):44. PubMed ID: 30134818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.